Searched for
APRETUDE
Twice-yearly shot could help end AIDS. But will it get to everyone who needs it?Gilead's twice-yearly HIV prevention shot was 100% effective in women and almost as good in men. The company will offer cheap generic versi...- Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning'The shots made by U.S. drugmaker Gilead and sold as Sunlenca are approved in the U.S., Canada, Europe and elsewhere, but only as a treatmen...
- European Commission authorises GSK's HIV prevention drugCabotegravir is recommended in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually-acqu...
- Load More